Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis

By Drucker Aaron  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite

A Caspase-6 and Anti-HER2 Antibody Chimeric Tumor-Targeted Proapoptotic Molecule Decreased Metastasis of Human Osteosarcoma

By Wang Li-Feng   Zhou Yong   Xu Yan-Ming   Qiu Xiu-Chun   Zhou Ben-Gen   Wang Fang   Long Hua   Chen Xiang   Yang Tong-Tao   Ma Bao-An   Fan Qing-Yu   Yang An-Gang  

Cancer Investigation, Vol. 27, Iss. 7, 2009-08 ,pp. : 774-780

Informa Healthcare

Access to resources Recommend Favorite

Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 9-18

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 639-645

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells

By Burks Scott  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 121-131

Springer Publishing Company

Access to resources Recommend Favorite